PB-026Purity on request
CIGB-300 (P15-Tat)
C₁₂₇H₂₁₅N₅₃O₃₀S₃
Anti-CK2 cyclic cell-penetrating research peptide.
Research Use Only · Oncology Research Peptides
CAS 1072877-99-6
Docs Documentation Available Upon Request
PB-029Purity on request
Fig. · Appearance on request
Oncology Research Peptides
iRGD (Certepide / CEND-1)
Formula / molecular weight on request
iRGD (Certepide / CEND-1) is a synthetic bifunctional cyclic peptide, described in source documentation as a 9-amino-acid structure stabilized by an intramolecular disulfide bridge. It belongs to the tumor-penetrating peptide (TPP) class and is studied as a drug-delivery-enhancement reagent for oncology, tumor-targeting, nanomedicine, and molecular-imaging research — including tumor-vasculature integrin targeting (αvβ3/αvβ5), vascular-permeability research, and co-administration studies with nanoparticles, antibodies, and imaging agents.
The source monograph's identifying data (CAS, molecular formula, molecular weight, and full sequence) for this entry duplicated an adjacent Tigapotide monograph in the source document and could not be treated as reliable for this compound. Only the compound identity, class, and research-function description above are drawn from verified text; the CAS number is instead taken from the internal product master list cross-check. Formula, molecular weight, and full sequence are shown as on request pending verified documentation.
Purity
On request
Quantity
Milligram, gram, or bulk quantities
Documentation
COA, HPLC, MS / LC-MS, SDS
Packaging
Bulk, non-branded, or private label
Research Use Only · Buyer verification required
Specifications
Technical profile.
Catalog Number
PB-029
CAS Number
2580154-02-3
Sequence
Not disclosed in source documentation
Molecular Formula
On request
Molecular Weight
On request
Purity (HPLC)
Available specifications confirmed with quotation
Appearance
On request
Vial Size
Confirmed with quotation
Storage
−20 °C, sealed, desiccated
Reconstitution
Bacteriostatic water
Classification
Research Use Only
Documentation & Quality
What documentation may be available for iRGD (Certepide / CEND-1).
iRGD (Certepide / CEND-1)·PB-029
Certificate of Analysis (COA)
Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.
Pending Verified Documentation
HPLC Chromatogram
Chromatographic data supporting the purity result reported for a batch.
Pending Verified Documentation
Mass Spectrometry (MS) Report
Mass spectrometry data supporting molecular identity confirmation.
Pending Verified Documentation
Endotoxin Test
Endotoxin testing result, where applicable to the product and its intended use.
Pending Verified Documentation
Safety Data Sheet (SDS)
Handling, storage, and safety information for the material.
Pending Verified Documentation
Third-Party Laboratory Report
Testing performed by an independent laboratory, separate from the manufacturing partner's own QC.
Pending Verified Documentation
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Inquire about pricing and availability.
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Related compounds.
View full catalogPB-027Purity on request
Tertomotide (GV1001) Hydrochloride
C₈₅H₁₄₇ClN₂₆O₂₁
Telomerase-derived 16-mer research peptide.
Research Use Only · Oncology Research Peptides
CAS 922174-60-5
Docs Documentation Available Upon Request
PB-028Purity on request
Tigapotide (PCK-3145)
C₈₂H₁₁₉N₂₁O₃₄S₃
PSP-94-derived antitumor research peptide.
Research Use Only · Oncology Research Peptides
CAS 848084-83-3
Docs Documentation Available Upon Request